Special Session

Presidential Symposium II - EL07 - Treatment of Oligometastatic Disease With RT Will Allow Survival to Soar in Low Income Nations

9/15/2019
10:15 AM - 11:45 AM
Location: Room W184

Session Type: Special Session
0.00 AMA PRA Category 1 Credits™

Following the Presidential Symposium, this Expanded Learning Session will focus on the question of whether or not treatment of oligometastatic disease using radiation therapy will improve survival outcomes in low- and middle-income countries. During the session, the speakers and audience will be asked to grapple with questions of treatment access, financial and human resources, training, and minimum requirements for safe and effective radiation delivery. The goals include: 1) to establish a baseline understanding of healthcare delivery in low and middle income countries; 2) to recognize regional differences in cancer incidence and cancer care; 3) to consider the factors that may impede broader use of radiation therapy; and 4) to discuss minimum requirements for safe and reliable ablative radiation therapy. We aim to accomplish these goals by tailoring this session to various learning styles including lectures, small group discussion, intergroup dialogue and case examples to reinforce learning points.

During this session attendees will hear 2 level setting talks and then be posed two questions. Groups will have time for discussion and then will report out their main points. From there moderators will present 2 cases and groups will have time for additional discussion. The session will end with a wrap up/summary.

Presentations:

May Abdel-Wahab, MD, PhD, FASTRO

International Atomic Energy Agency (IAEA)

Presentation(s):

Send Email for May Abdel-Wahab

Lilie Lin, MD

MD Anderson Cancer Center

Disclosure:
Employment
MD Anderson Cancer Center: Associate Professor: Employee;
Family: VA Hospital: Radiologist: Employee

Compensation
Astrazeneca: Research Grants: Travel Expenses

Biography:
Dr Lilie Lin is an Associate Professor in the Department of Radiation Oncology at the University of Texas, MD Anderson Cancer Center. Her clinical and research focus is on gynecologic malignancies, in particular she is the principal investigator of multiple clinical trials combining immunotherapy, DNA damage response inhibitors, or radiosensitizers with radiotherapy in gynecologic cancers to improve the therapeutic ratio. She also investigates novel PET tracers and MR sequences to interrogate the tumor microenvironment and understand tumor biology.

Presentation(s):

Send Email for Lilie Lin


Assets

Presidential Symposium II - EL07 - Treatment of Oligometastatic Disease With RT Will Allow Survival to Soar in Low Income Nations



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Presidential Symposium II - EL07 - Treatment of Oligometastatic Disease With RT Will Allow Survival to Soar in Low Income Nations